Featured Article
Researchers have presented a new technique to identify drug targets linked to abnormal protein phase separation in diseases such as Alzheimer's.
Precision Oncology Today
Magazine
Charging to the Frontline
Bispecific antibodies show promise in delivering immunotherapy with limited side effects and high response rates.
Cancer: The Next Microbiome Frontier
Three therapeutic regulatory approvals in less than a year signal that the promise of the human microbiome may finally be paying off. All of...
Trending on Inside Precision Medicine
AI-Driven Approach Identifies Drug Targets for Neurodegenerative Disorders
Researchers have presented a new technique to identify drug targets linked to abnormal protein phase separation in diseases such as Alzheimer's.
AcuraStem and Takeda Ink $580M Deal That Includes ALS Targets
Takeda and AcuraStem will jointly develop and commercialize AcuraStem's PIKFYVE targeted therapeutics for neurodegenerative diseases including ALS and frontotemporal dementia.
Stem Cell Transplantation Suitable for Treating Relapsing-Remitting MS
New research led by investigators at Uppsala University in Sweden shows emerging evidence that autologous hematopoietic stem cell transplantation (aHSCT) may be a suitable treatment for relapsing-remitting multiple sclerosis (MS).